Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 46, 604-610, February 1, 1986]
© 1986 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, K.
Right arrow Articles by Kuroki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, K.
Right arrow Articles by Kuroki, T.

Enhancement by 1{alpha},25-Dihydroxyvitamin D3 of Chemically Induced Transformation of BALB 3T3 Cells without Induction of Ornithine Decarboxylase or Activation of Protein Kinase C1

Kiyoshi Sasaki2, Kazuhiro Chida, Hiroki Hashiba, Nobuyuki Kamata, Etsuko Abe, Tatsuo Suda and Toshio Kuroki3

Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108 [K. S., K. C., H. H., N. K., T. K.]; and Department of Biochemistry, School of Dentistry, Showa University, Hatanodai, Shinagawa-ku, Tokyo 142 [E. A., T. S.], Japan

We reported previously that 1{alpha},25-dihydroxyvitamin D3 [1{alpha},25(OH)2D3], a hormonally active form of vitamin D3, markedly enhanced methylcholanthrene-induced transformation of BALB 3T3 A31-1-1 cells. When the cells were treated with methylcholanthrene (1 µg/ml) for 72 h and then with 1{alpha},25(OH)2D3 (5 ng/ml) for 2 wk, the transformation frequency was 1.95 ± 0.73 (SD) foci/dish in 8 independent experiments, which was about 20 times that in cultures treated with methylcholanthrene only. Even at a physiological concentration in plasma, i.e., 0.05 ng/ml, 1{alpha},25(OH)2D3 enhanced the transformation frequency significantly (P < 0.001). 1{alpha},25(OH)2D3 was not cytotoxic but slightly inhibited growth of the cells. Cells treated with 1{alpha},25(OH)2D3 were thin and became arranged in a meshwork with wide intercellular spaces. These morphological changes were reversible.

1{alpha},25(OH)2D3 induced DNA synthesis in quiescent BALB 3T3 cells dose and time dependently, but this effect was less than that of 12-O-tetradecanoylphorbol-13-acetate. Unlike 12-O-tetradecanoylphorbol-13-acetate, 1{alpha},25(OH)2D3 did not interfere with the binding of epidermal growth factor or phorbol dibutyrate. 1{alpha},25(OH)2D3 did not induce ornithine decarboxylase. Moreover, it did not activate protein kinase C in quiescent BALB 3T3 cells or this enzyme isolated from mouse brain.

BALB 3T3 cells and their transformants contain a specific cytosol receptor for 1{alpha},25(OH)2D3, but the binding sites of the transformants were fewer and had lower affinity than those of untransformed BALB 3T3 cells.

These effects of 1{alpha},25(OH)2D3 were specific, because other derivatives of vitamin D3 induced the same effects only at 200 times or more higher concentrations.

1 Supported in part by a grant for Cancer Research from the Ministry of Education, Science, and Culture of Japan.

2 Present address: National Institute of Hygienic Sciences, kamiyoga 1-18-1, Setagaya-ku, Tokyo 158, Japan.

3 To whom requests for reprints should be addressed.

Received 10/11/84. Revised 7/24/85. Revised 10/24/85. Accepted 10/25/85.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1986 by the American Association for Cancer Research.